Investment Summary |
|
---|---|
Date | 2017-01-01 |
Target | Foundation Risk Partners |
Sector | Insurance |
Investor(s) | Warburg Pincus |
Deal Type | Growth Capital |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1966 |
PE ASSETS | 83.0B USD |
Size | Mega |
Type | Sector Agnostic |
Warburg Pincus is a mega-sized, global private equity firm focused on investment opportunities across North America, Asia, and Europe. Warburg will consider investing at various company stages, from early-stage opportunities to distressed situations. Warburg Pincus is organized by industry groups. Verticals include financial services, healthcare, technology, media & telecommunications, energy, consumer & industrial, and real estate. Within financial services, Warburg will consider asset/wealth managers, banks, exchanges, financial technology, insurance, transaction processing, private banking, and specialty/consumer finance. Within healthcare, specific areas of interest include medical devices, healthcare services, and biotech/pharmaceuticals. Within technology/media/communications, Warburg targets software, media/internet/information, financial technology, telecom, business services, and systems/semiconductors. Within energy, specific areas of interest include oil/gas exploration, power generation/transmission, and alternative energy. Warburg Pincus raised its first fund in 1966 and is based in New York City.
DEAL STATS | # |
---|---|
Overall | 329 of 482 |
Sector (Insurance) | 9 of 17 |
Type (Growth Capital) | 107 of 158 |
State (Florida) | 6 of 12 |
Country (United States) | 169 of 237 |
Year (2017) | 6 of 28 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-01-01 |
Taiji Data
China Taiji Data is a carrier-neutral data center operator based in China. The goal of Taiji is to capitalize on the rapid growth in China’s data center sector and to create a leading wholesale data center platform (the Digital Realty of China) through greenfield developments, brownfield conversions and acquisitions in Tier 1 cities and surrounding areas, as well as in select Tier 2 cities in China. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-01-20 |
Accriva Diagnostics
San Diego, California, United States Accriva Diagnostics is a leader in hemostasis management and POC testing. Accriva develops, manufactures, and markets: Hemochron® and ProTime® POC coagulation systems; IRMA TruPoint® Blood Gas and Electrolyte systems; Avoximeter® CO-Oximetry systems; and Tenderfoot®, Tenderlett® and Surgicutt® skin incision products. |
Sell | - |